Medical/Healthcare News

Tavanta Therapeutics Announces New Preclinical Data for its Cystic Fibrosis Candidate TAVT-135 at Two Prominent Scientific Conferences

KING OF PRUSSIA, PA — Tavanta Therapeutics announced presentations of new preclinical data for TAVT–135, a novel inhaled chloride ion transporter in development for pan-genotypic treatment of cystic fibrosis (CF). …

Tavanta Therapeutics Announces New Preclinical Data for its Cystic Fibrosis Candidate TAVT-135 at Two Prominent Scientific Conferences Read More

Zynerba Pharmaceuticals

Zynerba Pharmaceuticals to Showcase Cutting-Edge Cannabinoid Therapies for Neuropsychiatric Disorders at ASCP 2023

DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced an oral podium presentation and poster presentations at the American Society of Clinical Psychopharmacology Annual Meeting (ASCP 2023), being held May …

Zynerba Pharmaceuticals to Showcase Cutting-Edge Cannabinoid Therapies for Neuropsychiatric Disorders at ASCP 2023 Read More


InterDigital